Previous studies have described the expression of MMPs in epithelial ovarian cancer and evaluated the presence of MMP-2 and MMP-9 in the tumor as potential biomarkers of aggressiveness of the malignancy, registering the disease-free period and the overall survival of patients [13–18]. This evidence concerns the gene MMP9 and ovarian carcinoma.